Anbio Biotechnology (NNNN) Current Assets (2023 - 2025)

Anbio Biotechnology has reported Current Assets over the past 3 years, most recently at $30.2 million for Q4 2025.

  • Quarterly results put Current Assets at $30.2 million for Q4 2025, up 63.17% from a year ago — trailing twelve months through Dec 2025 was $30.2 million (up 63.17% YoY), and the annual figure for FY2025 was $30.2 million, up 63.17%.
  • Current Assets for Q4 2025 was $30.2 million at Anbio Biotechnology, up from $18.5 million in the prior quarter.
  • Over the last five years, Current Assets for NNNN hit a ceiling of $30.2 million in Q4 2025 and a floor of $15.7 million in Q4 2023.
  • Median Current Assets over the past 3 years was $18.5 million (2024), compared with a mean of $21.5 million.
  • Biggest five-year swings in Current Assets: rose 17.68% in 2024 and later skyrocketed 63.17% in 2025.
  • Anbio Biotechnology's Current Assets stood at $15.7 million in 2023, then grew by 17.68% to $18.5 million in 2024, then skyrocketed by 63.17% to $30.2 million in 2025.
  • The last three reported values for Current Assets were $30.2 million (Q4 2025), $18.5 million (Q4 2024), and $15.7 million (Q4 2023) per Business Quant data.